Alivus Life Sciences Faces Rs. 2.6 Crore Tax Demand from Income Tax Department

Alivus Life Sciences Ltd. has received an order from the Income Tax Department, Faceless Assessment Unit, under Section 143(1) read with Section 144B of the Income Tax Act, 1961, dated 20th March, 2026. The order pertains to the Assessment Year 2023-24 (Financial Year 2022-23) and includes a tax demand of Rs. 2,60,67,810 on account of disallowances of expenditure under Section 37(1). The company has stated that there is no material impact on financial activities, no impact on operations, or other activities of the company due to the intimation of tax payable. The order is currently appealable before the appellate authority and the company will make an assessment to exercise the right to appeal.